Related references
Note: Only part of the references are listed.4th Global CRO Council for Bioanalysis: coadministered drugs stability, EMA/US FDA Guidelines, 483s and Carryover
Steve Lowes et al.
BIOANALYSIS (2012)
Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC)
Mark Boterman et al.
BIOANALYSIS (2012)
Validation of immunoassay for protein biomarkers: Bioanalytical study plan implementation to support pre-clinical and clinical studies
Marie-Anne Valentin et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2011)
The 3rd Global CRO Council for Bioanalysis at the International Reid Bioanalytical Forum
Massimo Breda et al.
BIOANALYSIS (2011)
Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the Global CRO Council for Bioanalysis
Steve Lowes et al.
BIOANALYSIS (2011)
Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs
J. Cummings et al.
BRITISH JOURNAL OF CANCER (2010)
Systematic analytical validation of commercial kits for the determination of novel biomarkers for clinical drug development
William Nowatzke et al.
BIOANALYSIS (2010)
Formation of a Global Contract Research Organization Council for Bioanalysis
Noel Premkumar et al.
BIOANALYSIS (2010)
Tartrate-resistant acid phosphatase (TRACP 5b): A biomarker of bone resorption rate in support of drug development: Modification, validation and application of the BoneTRAP® kit assay
Yuling Wu et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Validation of Analytic Methods for Biomarkers Used in Drug Development
Cindy H. Chau et al.
CLINICAL CANCER RESEARCH (2008)
Fit-for-purpose method development and validation for successful biomarker measurement
JW Lee et al.
PHARMACEUTICAL RESEARCH (2006)
Share Paper
